News Now

Bhawanipur Global Campus Announces iNATCONPH 2026: A Global Platform for Pharmacy & Allied Health Research

Kolkata: Bhawanipur Global Campus has announced the 16th International Conference - iNATCONPH 2026, a prestigious international scientific conference that will be held on 8–9 October 2026 in Kolkata. The...

Emcure Pharma Receives CDSCO Approval to Launch Poviztra®️ for Fatty Liver Disease Treatment

Emcure Pharmaceuticals Ltd  announced that its co-marketed semaglutide brand, Poviztra®, has received regulatory approval from the Central Drugs...

CDSCO Partners with THSTI to Strengthen Vaccine and Healthcare innovation

The Central Drugs Standard Control Organization (CDSCO), India’s national regulatory authority, and the Translational Health Science and Technology...

EMeRG Launches Hospital Intel Suite™️ to transform MedTech Market

EMeRG, a leading healthcare intelligence provider with over a decade of industry expertise,  announced the launch of Hospital...

CDSCO Issues Final Guidance for Medical Device Software Under MDR 2017

The Central Drugs Standard Control Organisation (CDSCO), functioning under the Directorate General of Health Services, Ministry of Health...

FDA Approves Datroway for Metastatic Triple-Negative Breast Cancer

AstraZeneca and Daiichi Sankyo  announced that the US Food and Drug Administration (FDA) has approved Datroway(datopotamab deruxtecan) for adult patients with unresectable or metastatic triple-negative breast cancer (TNBC)...

Medicare Now Covers Obesity Drugs: Affordable GLP-1 Access Begins

In a landmark shift for American healthcare, Medicare has begun covering GLP-1 medications — including semaglutide (Wegovy) and tirzepatide(Zepbound) — for patients with obesity and related conditions,...

India’s CDSCO Bans Injectable Products From Being Marketed as Cosmetics

The Central Drugs Standard Control Organisation (CDSCO), Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India, has issued a...

Sun Pharma Reports Strong Q4 with 26% Growth in Net Profit

Sun Pharmaceutical Industries Limited reported a strong fourth quarter for FY26, with consolidated net profit rising 26.2% year-on-year to ₹2,714 crore. Revenue for the quarter...

West Bengal Healthcare Gets Major Boost as Centre Reviews Key Health Schemes

Union Health Minister Jagat Prakash Nadda held a virtual review meeting with West Bengal officials to assess the state’s healthcare systems and discuss ways to strengthen...

J P Nadda Speaks on TB Prevention at Geneva Global Health Summit

India reinforced its commitment to tuberculosis prevention and stronger lung health screening as Union Health Minister Jagat Prakash Nadda addressed a key side-event on “Ministerial Perspectives...